Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cancer susceptibility 19 | 0.769 | 0.423 |
|
disease | 0.100 | None | 1.000 | 8 | 12 | 2007 | 2013 | |||||||||
|
autophagy related 16 like 1 | 0.543 | 0.769 | 0.96 |
|
disease | 0.700 | None | 0.953 | 8 | 5 | 2001 | 2020 | ||||||||
|
solute carrier family 2 member 9 | 0.619 | 0.731 | 6.9E-10 |
|
disease | 0.120 | None | 1.000 | 8 | 349 | 2007 | 2019 | ||||||||
|
solute carrier family 2 member 9 | 0.619 | 0.731 | 6.9E-10 |
|
disease | 0.400 | None | 1.000 | 8 | 349 | 2007 | 2019 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 8 | 8 | 2002 | 2020 | ||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.100 | None | 1.000 | 7 | 31 | 2009 | 2016 | |||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
disease | 0.190 | None | 1.000 | 7 | 2 | 2008 | 2017 | ||||||||
|
long intergenic non-protein coding RNA 2210 | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 7 | 5 | 2009 | 2016 | |||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
disease | 0.500 | None | 0.971 | 7 | 3 | 2008 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 0.927 | 7 | 4 | 1982 | 2020 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.500 | None | 0.984 | 7 | 4 | 2001 | 2019 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
disease | 0.170 | None | 1.000 | 6 | 1 | 2007 | 2019 | |||||||||
|
prostate cancer associated non-coding RNA 1 | 0.722 | 0.385 |
|
disease | 0.170 | None | 1.000 | 6 | 4 | 2008 | 2019 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 6 | 221 | 2007 | 2014 | |||||||||
|
high mobility group 20A | 0.890 | 0.154 | 0.68 |
|
disease | 0.480 | None | 1.000 | 6 | 2 | 2011 | 2018 | ||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.130 | None | 0.889 | 6 | 149 | 2007 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 6 | 7 | 2008 | 2020 | ||||||||
|
C-C motif chemokine receptor 6 | 0.485 | 0.808 | 5.8E-03 |
|
disease | 0.500 | None | 1.000 | 6 | 8 | 2001 | 2019 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.200 | None | 1.000 | 6 | 3 | 2011 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 6 | 15 | 2007 | 2020 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.200 | None | 0.915 | 6 | 72 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.936 | 6 | 4 | 1989 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 6 | 4 | 2008 | 2011 | |||||||||
|
chromosome 1 open reading frame 141 | 0.691 | 0.385 | 3.2E-03 |
|
disease | 0.100 | None | 1.000 | 6 | 16 | 2006 | 2019 | ||||||||
|
gasdermin B | 0.670 | 0.500 | 3.3E-07 |
|
disease | 0.500 | None | 1.000 | 6 | 12 | 2007 | 2019 |